ALECO Fundamental Analysis - ECOMIAM SA

Fundamental Rating

Overall ALECO gets a fundamental rating of 3 out of 10. We evaluated ALECO against 25 industry peers in the Consumer Staples Distribution & Retail industry. While ALECO seems to be doing ok healthwise, there are quite some concerns on its profitability. ALECO is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALECO has reported negative net income.

In the past year ALECO has reported a negative cash flow from operations.

In multiple years ALECO reported negative net income over the last 5 years.

ALECO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

ALECO has a Return On Assets of -27.01%. This is amonst the worse of the industry: ALECO underperforms 96.00% of its industry peers.

Looking at the Return On Equity, with a value of -57.36%, ALECO is doing worse than 92.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-27.01%
ROE	-57.36%
ROIC	N/A

ROA(3y)-25.33%

ROA(5y)-12.63%

ROE(3y)-57.45%

ROE(5y)-9.56%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 39.84%, ALECO belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.

In the last couple of years the Gross Margin of ALECO has grown nicely.

The Profit Margin and Operating Margin are not available for ALECO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	39.84%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.82%

GM growth 5Y4.19%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALECO does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALECO has more shares outstanding

ALECO has more shares outstanding than it did 5 years ago.

ALECO has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.56 indicates that ALECO is not a great score, but indicates only limited risk for bankruptcy at the moment.

ALECO has a Altman-Z score of 2.56. This is in the lower half of the industry: ALECO underperforms 68.00% of its industry peers.

A Debt/Equity ratio of 0.21 indicates that ALECO is not too dependend on debt financing.

ALECO's Debt to Equity ratio of 0.21 is amongst the best of the industry. ALECO outperforms 96.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF	N/A
Altman-Z	2.56

ROIC/WACCN/A

WACC7.06%

2.3 Liquidity

ALECO has a Current Ratio of 2.03. This indicates that ALECO is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of ALECO (2.03) is better than 100.00% of its industry peers.

A Quick Ratio of 1.08 indicates that ALECO should not have too much problems paying its short term obligations.

ALECO's Quick ratio of 1.08 is amongst the best of the industry. ALECO outperforms 96.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.03
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.42% over the past year.

Looking at the last year, ALECO shows a decrease in Revenue. The Revenue has decreased by -2.57% in the last year.

Measured over the past years, ALECO shows a very strong growth in Revenue. The Revenue has been growing by 22.39% on average per year.

EPS 1Y (TTM)62.42%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%48.94%

Revenue 1Y (TTM)-2.57%

Revenue growth 3Y3.67%

Revenue growth 5Y22.39%

Sales Q2Q%-4.04%

3.2 Future

The Earnings Per Share is expected to grow by 28.44% on average over the next years. This is a very strong growth

Based on estimates for the next years, ALECO will show a very strong growth in Revenue. The Revenue will grow by 29.40% on average per year.

EPS Next Y9.52%

EPS Next 2Y24.4%

EPS Next 3Y28.44%

EPS Next 5YN/A

Revenue Next Year0.98%

Revenue Next 2Y16.74%

Revenue Next 3Y29.4%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALECO. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALECO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALECO's earnings are expected to grow with 28.44% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.4%

EPS Next 3Y28.44%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALECO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ECOMIAM SA

EPA:ALECO (12/4/2025, 7:00:00 PM)

1.735

+0.02 (+0.87%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupConsumer Staples Distribution & Retail

GICS IndustryConsumer Staples Distribution & Retail

Earnings (Last)11-11 2025-11-11/amc

Earnings (Next)N/A N/A

Inst Owners0.83%

Inst Owner ChangeN/A

Ins Owners3.45%

Ins Owner ChangeN/A

Market Cap9.30M

Revenue(TTM)40.37M

Net Income(TTM)-3.19M

Analysts86.67

Price Target3.06 (76.37%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-13.26%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.23
P/FCF	N/A
P/OCF	N/A
P/B	1.67
P/tB	1.75
EV/EBITDA	N/A

EPS(TTM)-0.59

EYN/A

EPS(NY)-0.2

Fwd EYN/A

FCF(TTM)-0.33

FCFYN/A

OCF(TTM)-0.27

OCFYN/A

SpS7.53

BVpS1.04

TBVpS0.99

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-27.01%
ROE	-57.36%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	39.84%
FCFM	N/A

ROA(3y)-25.33%

ROA(5y)-12.63%

ROE(3y)-57.45%

ROE(5y)-9.56%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.82%

GM growth 5Y4.19%

F-Score4

Asset Turnover3.42

Health

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	96.12%
Cap/Sales	0.78%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.03
Quick Ratio	1.08
Altman-Z	2.56

F-Score4

WACC7.06%

ROIC/WACCN/A

Cap/Depr(3y)90.44%

Cap/Depr(5y)244.65%

Cap/Sales(3y)1.42%

Cap/Sales(5y)2.48%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)62.42%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%48.94%

EPS Next Y9.52%

EPS Next 2Y24.4%

EPS Next 3Y28.44%

EPS Next 5YN/A

Revenue 1Y (TTM)-2.57%

Revenue growth 3Y3.67%

Revenue growth 5Y22.39%

Sales Q2Q%-4.04%

Revenue Next Year0.98%

Revenue Next 2Y16.74%

Revenue Next 3Y29.4%

Revenue Next 5YN/A

EBIT growth 1Y16%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year45.45%

EBIT Next 3Y47.08%

EBIT Next 5YN/A

FCF growth 1Y-10.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-20.8%

OCF growth 3YN/A

OCF growth 5YN/A

ECOMIAM SA / ALECO.PA FAQ

Can you provide the ChartMill fundamental rating for ECOMIAM SA?

ChartMill assigns a fundamental rating of 3 / 10 to ALECO.PA.

What is the valuation status for ALECO stock?

ChartMill assigns a valuation rating of 1 / 10 to ECOMIAM SA (ALECO.PA). This can be considered as Overvalued.

How profitable is ECOMIAM SA (ALECO.PA) stock?

ECOMIAM SA (ALECO.PA) has a profitability rating of 2 / 10.

How financially healthy is ECOMIAM SA?

The financial health rating of ECOMIAM SA (ALECO.PA) is 5 / 10.

ECOMIAM SA (ALECO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ECOMIAM SA / ALECO.PA FAQ

Can you provide the ChartMill fundamental rating for ECOMIAM SA?

What is the valuation status for ALECO stock?

How profitable is ECOMIAM SA (ALECO.PA) stock?

How financially healthy is ECOMIAM SA?